Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Juan C Ramos
AIDS Malignancy Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Jackson Hospital and Clinic
Montgomery, Alabama, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Ucla Center for Clinical Aids Research and Education
Los Angeles, California, United States
- San Diego Va Medical Center
San Diego, California, United States
- Ucsf Medical Center-Parnassus
San Francisco, California, United States
- Zuckerberg San Francisco General Hospital
San Francisco, California, United States
- Jackson Memorial Hospital-Holtz Children'S Hospital
Miami, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Kendall
Miami, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- John H Stroger Jr Hospital of Cook County
Chicago, Illinois, United States
- Northwestern University
Chicago, Illinois, United States
- Stroger Hospital of Cook County Mbccop
Chicago, Illinois, United States
- Louisiana State University Health Science Center
New Orleans, Louisiana, United States
- University Medical Center New Orleans
New Orleans, Louisiana, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Boston Medical Center
Boston, Massachusetts, United States
- Siteman Cancer Center at Washington University
St Louis, Missouri, United States
- Washington University - Jewish
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Montefiore Medical Center - Moses Campus
The Bronx, New York, United States
- Montefiore Medical Center-Einstein Campus
The Bronx, New York, United States
- Montefiore Medical Center-Weiler Hospital
The Bronx, New York, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Pennsylvania Hospital
Philadelphia, Pennsylvania, United States
- Miriam Hospital
Providence, Rhode Island, United States
- Baylor College of Medicine/dan L Duncan Comprehensive Cancer Center
Houston, Texas, United States
- Ben Taub General Hospital
Houston, Texas, United States
- Thomas Street Clinic
Houston, Texas, United States
- Harborview Medical Center
Seattle, Washington, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
- Virginia Mason Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Oct 2010
- Primary completion
- 12 Nov 2016
- Completion
- 19 May 2022
- Last update posted
- 21 Nov 2023
- Registered enrollment
- 107
- Registry id
- NCT01193842
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.